Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 22 , ISSUE 4 ( 2018 ) > List of Articles

CASE REPORT

First reported case of respiratory syncytial virus infection causing guillain–Barré syndrome

Scott Helgeson, Alexander Heckman, Dana Harris

Keywords : Acute immune-mediated polyneuropathy, ribavirin, respiratory syncytial virus

Citation Information : Helgeson S, Heckman A, Harris D. First reported case of respiratory syncytial virus infection causing guillain–Barré syndrome. Indian J Crit Care Med 2018; 22 (4):309-310.

DOI: 10.4103/ijccm.IJCCM_171_17

License: CC BY-ND 3.0

Published Online: 01-04-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Acute immune-mediated polyneuropathies are a group of illnesses that cause paralysis following an infection. We describe a case of one of these illnesses being caused by the respiratory syncytial virus (RSV). An 81-year-old female was admitted for an RSV infection. She went into respiratory failure requiring intubation and mechanical ventilation and treatment with ribavirin. When she was extubated, she had bilateral lower extremity weakness and absent reflexes. Her disease progressed rapidly to involve her diaphragm, and eventually, the family agreed to let the natural death process occur. Our case is the first reported case in which an acute immune-mediated polyneuropathy was caused from an RSV infection.


PDF Share
  1. Yuki N, Hartung HP. Guillain-barré syndrome. N Engl J Med 2012;366:2294-304.
  2. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-9.
  3. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-6.
  4. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: Incidence and mortality rates in US hospitals. Neurology 2008;70:1608-13.
  5. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014;137:33-43.
  6. The Guillain-Barre Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
  7. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-30.
  8. van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré study group. N Engl J Med 1992;326:1123-9.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.